Marshall Wace, LLP Clarus Therapeutics Hldgs Inc Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
A detailed history of Marshall Wace, LLP transactions in Clarus Therapeutics Hldgs Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 63,063 shares of CRXTW stock, worth $630. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,063Holding current value
$630% of portfolio
0.0%Shares
0 transactions
Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
---|